Old Web
English
Sign In
Acemap
>
authorDetail
>
Ravindra A. De Silva
Ravindra A. De Silva
Johns Hopkins University School of Medicine
Chemistry
Nuclear medicine
Process validation
Phases of clinical research
Toxicity
2
Papers
0
Citations
0
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (2)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Pharmacodynamic measures within tumors expose differential activity of PD(L)-1 antibody therapeutics.
2021
Proceedings of the National Academy of Sciences of the United States of America
Dhiraj Kumar
Akhilesh Mishra
Ala Lisok
Rakeeb Kureshi
Sagar Shelake
Donika Plyku
Rupashree Sen
Michele Doucet
Ravindra A. De Silva
Ronnie C. Mease
Patrick M. Forde
Elizabeth M. Jaffee
Prashant Desai
Sudipto Ganguly
Edward Gabrielson
Dhananjay Vaidya
Jamie B. Spangler
Sridhar Nimmagadda
Show All
Source
Cite
Save
Citations (0)
Process validation, current good manufacturing practice production, dosimetry, and toxicity studies of the carbonic anhydrase IX imaging agent [111 In]In-XYIMSR-01 for phase I regulatory approval.
2021
Journal of Labelled Compounds and Radiopharmaceuticals
Ravindra A. De Silva
Michael A. Gorin
Ronnie C. Mease
Il Minn
Ala Lisok
Donika Plyku
Sridhar Nimmagadda
Mohamad E. Allaf
Xing Yang
George Sgouros
Steven P. Rowe
Martin G. Pomper
Show All
Source
Cite
Save
Citations (0)
1